Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moringa Oleifera Extract vs Sodium Hypochlorite in Pulpectomy
NCT06948526Not yet recruiting
- Sponsor
- Cairo University
- Start
- Jun 2025
- Primary completion
- Jun 2026
- Modality
- PE (Plant Extract), Dietary Supplement
- Countries
- 1
01
Overview
Randomised trial of moringa oleifera in pulp necrosis (2 arms), sponsored by Cairo University. Primary endpoints: Postoperative Pain at 12 months, Soft Tissue Healing at 12 months and 1 more. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
moringa oleifera
03
Conditions
pulp necrosis
Beyond the preview
Go deeper on NCT06948526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06948526.